logo
  1. Home
  2. Stocks
  3. Glenmark Life Sciences

Glenmark Life Sciences Share Price

Small Cap | Pharmaceuticals and health care | NSE: ALIVUS | BSE: 543322

₹1,001.05 image-64.35 (-6.04 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 1,056.00

High (₹) 1,064.45

Low (₹) 995.20

Prev. Close (₹) 1,065.40

Volume 1,01,316

VWAP (₹) 887.36

ROCE (%) 26.24

Industry P/E 44.73

TTM P/E 27.77

P/B Ratio 5.26

Market Cap (₹) Cr.12,266.57

Dividend Yield (%)2.25

EPS (₹) 38.38

ROE20.16%

Sales Growth (%) 5.64

Profit Growth (%)0.84

Day Range

1,064.451,064.45

L
H

52 Week Range

743.601,335.00

L
H

Historical Returns

Returns (6M)

-11.54 %

Returns (1Y)

22.48 %

Returns (3Y)

97.58 %

Returns (5Y)

33.74 %

Returns (6M)

-11.54 %

Returns (1Y)

22.48 %

Returns (3Y)

97.58 %

Returns (5Y)

33.74 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 55.03

MFI 15.20

ATR 66.35

Commodity Channel Index -135.59

ROC125 -12.05

ROC21 -24.17

Williams %R -97.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current906.01927.13943.26889.88868.76852.63831.51
Week Ago1,053.241,090.121,120.741,022.62985.74955.12918.24
Month Ago1,228.341,303.421,356.941,174.821,099.741,046.22971.14

EMA & SMA
info_icon

1001.05

Current Price

EMA & SMApin

Bullish Moving Averages

5

Bearish Moving Averages

15

5 Day 971.32

9 Day 1002.66

10 Day 995.28

12 Day 1017.10

14 Day 1043.70

20 Day 1082.64

26 Day 1100.94

50 Day 1066.81

100 Day 1076.43

200 Day 1012.32

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUNDbulkBuy09 Aug, 2021₹732.558,36,000NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell06 Aug, 2021₹766.129,51,097NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy06 Aug, 2021₹765.779,51,097NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
15 Jul, 2024Glenn Mario SaldanhaDisposal₹829.637,800NSE
15 Jul, 2024Glenmark Pharmaceuticals LimitedDisposal₹830.7396,09,571NSE
13 Mar, 2024Nirma LimitedAcquisition₹598.592,45,05,435NSE
13 Mar, 2024Glenmark Pharmaceuticals LimitedDisposal₹597.992,45,05,435NSE
07 Mar, 2024Glenmark Pharmaceuticals LimitedDisposal₹597.996,73,89,944NSE
25 Sept, 2023Glenmark Pharmaceuticals LimitedPledge₹615.0096,09,571NSE
17 Nov, 2021GLENN SALDANHAAcquisition₹643.197,505NSE
17 Nov, 2021GLENN SALDANHAAcquisition₹640.77295NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
04 Oct, 2023Rs.22.5000 per share(1125%)Interim Dividend17 Oct, 202317 Oct, 2023
14 Mar, 2023Rs.21.0000 per share(1050%)Interim Dividend24 Mar, 202324 Mar, 2023
20 Apr, 2022Rs.10.5000 per share(525%)Final Dividend15 Sept, 202201 Jan, 1970

Announcements

DateSourceDetail
03 Apr, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange about General Updates
03 Apr, 2025BSE IndiaIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
02 Apr, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange regarding Acquisition
02 Apr, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange about Acquisition
02 Apr, 2025BSE IndiaIntimation of Share Purchase cum Subscription Shareholders'' Agreement and Power Supply Agreement between Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) and Torrent Urja 19 Private Limited.
07 Mar, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange regarding Allotment of Securities
07 Mar, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange regarding Allotment of 4190 equity Shares.
07 Mar, 2025BSE IndiaAllotment of Equity Shares under the ''Glenmark Life Sciences Limited - Employee Stock Option Scheme 2021''.
03 Mar, 2025NSE IndiaAlivus Life Sciences Limited has informed the Exchange about Schedule of meet
03 Mar, 2025BSE IndiaDisclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--17 Jan, 202523 Jan, 2025
Quarterly Results--17 Oct, 202424 Oct, 2024
Quarterly Results--19 Jul, 202425 Jul, 2024
Audited Results--19 Apr, 202425 Apr, 2024
Quarterly Results--16 Jan, 202423 Jan, 2024
Quarterly Results--16 Oct, 202320 Oct, 2023
Interim Dividend--05 Oct, 202309 Oct, 2023
Quarterly Results--14 Jul, 202321 Jul, 2023
Audited Results--20 Apr, 202327 Apr, 2023
Interim Dividend--10 Mar, 202316 Mar, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021
Promoter Group75%82.85%82.85%82.84%0%
Foreign Institutions +6.74%4.57%4.45%8.32%0%
Domestic Institutions +4.86%0.74%0.08%0.47%0%
Government0%0%0%0%0%
Public13.4%11.84%12.62%8.37%0%
Others0%0%0%0%0%

About Glenmark Life Sciences

Glenmark Life Sciences is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2283.21 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

2011

Managing Director

Dr. Yasir Rawjee

NSE Symbol

GLS

Glenmark Life Sciences Management

NameDesignation
Mr. Hiren K PatelChairman & Non-Exe.Director
Dr. Yasir RawjeeManaging Director & CEO
Mr. Vinod NaikExecutive Director
Mrs. Manju AgarwalIndependent Director
Mr. Taruvai Laxminarayanan EaswarIndependent Director
Mr. Kaushikbhai N PatelIndependent Director
Mr. Vijaykumar ShahIndependent Director
Dr. Savan GodiawalaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Glenmark Life Sciences

What is the share price of Glenmark Life Sciences?

The share price of Glenmark Life Sciences on 04 Apr, 2025 is ₹ 1,001.05.

What is 52W high and 52W low share price of Glenmark Life Sciences?

The highest and lowest 52W share prices of Glenmark Life Sciences are ₹ 1335.000 and ₹ 743.600

What is the market cap of Glenmark Life Sciences?

The market capitalization of Glenmark Life Sciences as of 04 Apr, 2025 is ₹ 12,266.57 Crores

What is the P/E ratio of Glenmark Life Sciences?

The current P/E ratio of Glenmark Life Sciences as of 04 Apr, 2025 is 44.73

What is the PB ratio of Glenmark Life Sciences?

The PB ratio of Glenmark Life Sciences as of 04 Apr, 2025 is 5.26

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited